Setting the stage: Host invasion by HIV

Nature Reviews Immunology

Volumn 8, Issue 6, 2008, Pages 447-457

  Hladik, Florian ^a,b   McElrath, M Juliana ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN;

ANUS INTERCOURSE; CD4+ T LYMPHOCYTE; CELL ADHESION; CELL INVASION; DENDRITIC CELL; ENDOCYTOSIS; EXOSOME; FEMALE GENITAL SYSTEM; GASTROINTESTINAL TRACT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LAMINA PROPRIA; MALE GENITAL SYSTEM; PHAGOSOME; PINOCYTOSIS; PRIORITY JOURNAL; REVIEW; SEXUAL INTERCOURSE; UTERINE CERVIX MUCOSA; VAGINA MUCOSA; VIRUS TRANSMISSION;

ANIMALS; HIV INFECTIONS; HIV-1; HUMANS;

EID: 44349159423     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2302     Document Type: Review

References (129)

1. Kell, P. D., Barton, S. E., Edmonds, D. K. & Boag, F. C. HIV infection in a patient with Meyer-Rokitansky-Kuster-Hauser syndrome. J. R. Soc. Med. 85, 706-707 (1992).
2. Miller, C. J., Alexander, N. J., Vogel, P., Anderson, J. & Marx, P. A. Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J. Med. Primatol. 21, 64-68 (1992).
3. Padian, N. S. et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 370, 251-261 (2007).
4. Howell, A. L. et al. Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract. J. Virol. 71, 3498-3506 (1997).
5. + T cells, and AIDS. J. Virol. 71, 4016-4023 (1997).
6. Phillips, D. M., Tan, X., Perotti, M. E. & Zacharopoulos, V. R. Mechanism of monocyte-macrophage-mediated transmission of HIV. AIDS Res. Hum. Retroviruses 14, S67-S70 (1998).
7. Alfsen, A., Yu, H., Magerus-Chatinet, A., Schmitt, A. & Bomsel, M. HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer. Mol. Biol. Cell 16, 4267-4279 (2005).
8. Sourisseau, M., Sol-Foulon, N., Porrot, F., Blanchet, F. & Schwartz, O. Inefficient human immunodeficiency virus replication in mobile lymphocytes. J. Virol. 81, 1000-1012 (2007).
9. Muratori, C. et al. Macrophages transmit human immunodeficiency virus type 1 products to CD4-negative cells: involvement of matrix metalloproteinase 9. J. Virol. 81, 9078-9087 (2007).
10. Van Herrewege, Y. et al. A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides. Antiviral Res. 74, 111-124 (2007).
11. Kaizu, M. et al. Repeated intravaginal inoculation with cell-associated simian immunodeficiency virus results in persistent infection of nonhuman primates. J. Infect. Dis. 194, 912-916 (2006).
12. Khanna, K. V. et al. Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J. Clin. Invest. 109, 205-211 (2002).
13. Zhu, T. et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J. Virol. 70, 3098-3107 (1996).
14. + T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J. Virol. 76, 9868-9876 (2002).
15. Zussman, A., Lara, L., Lara, H. H., Bentwich, Z. & Borkow, G. Blocking of cell-free and cell-associated HIV-1 transmission through human cervix organ culture with UC781. AIDS 17, 653-661 (2003).
16. Maher, D., Wu, X., Schacker, T., Horbul, J. & Southern, P. HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proc. Natl Acad. Sci. USA 102, 11504-11509 (2005).
17. Miller, C. J. et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J. Virol. 79, 9217-9227 (2005).
18. Dezzutti, C. S. et al. Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J. Infect. Dis. 183, 1204-1213 (2001).
19. + cells: implications for mechanisms of sexual transmission. J. Infect. Dis. 188, 1473-1482 (2003).
20. Berlier, W. et al. Selective sequestration of X4 isolates by human genital epithelial cells: Implication for virus tropism selection process during sexual transmission of HIV. J. Med. Virol. 77, 465-474 (2005).
21. Bomsel, M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nature Med. 3, 42-47 (1997). This study introduced the concept of HIV-1 transcytosis, a process by which intact virions are transported through the interior of epithelial cells, thereby retaining their infectivity.
22. Bobardt, M. D. et al. Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J. Virol. 81, 395-405 (2007).
23. Greenhead, P. et al. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J. Virol. 74, 5577-5586 (2000).
24. Ibata, B., Parr, E. L., King, N. J. & Parr, M. B. Migration of foreign lymphocytes from the mouse vagina into the cervicovaginal mucosa and to the iliac lymph nodes. Biol. Reprod. 56, 537-543 (1997).
25. + T cells, and that viral fusion predominates in T cells and viral endocytosis in LCs.
26. Munch, J. et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131, 1059-1071 (2007). The authors discovered that amyloidogenic fragments of prostatic acidic phosphatase in semen can serve as strong enhancing factors for HIV infection.
27. Furuta, Y. et al. Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc. Natl Acad. Sci. USA 91, 12559-12563 (1994).
28. Yeaman, G. R. et al. Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology 113, 524-533 (2004).
29. Stoddard, E. et al. gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission. J. Immunol. 179, 3126-3132 (2007).
30. Hu, J., Gardner, M. B. & Miller, C. J. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 74, 6087-6095 (2000).
31. Nishibu, A. et al. Behavioral responses of epidermal Langerhans cells in situ to local pathological stimuli. J. Invest. Dermatol. 126, 787-796 (2006).
32. Miller, C. J., McChesney, M. & Moore, P. F. Langerhans cells, macrophages and lymphocyte subsets in the cervix and vagina of rhesus macaques. Lab. Invest. 67, 628-634 (1992).
33. Rescigno, M. et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nature Immunol. 2, 361-367 (2001).
34. Niess, J. H. et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307, 254-258 (2005).
35. Norvell, M. K., Benrubi, G. I. & Thompson, R. J. Investigation of microtrauma after sexual intercourse. J. Reprod. Med. 29, 269-271 (1984).
36. mac239. J. Virol. 82, 4154-4158 (2008).
37. Tschachler, E. et al. Epidermal Langerhans cells - a target for HTLV-III/LAV infection. J. Invest. Dermatol. 88, 233-237 (1987).
38. Zaitseva, M. et al. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nature Med. 3, 1369-1375 (1997).
39. Dittmar, M. T. et al. Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups. J. Virol. 71, 8008-8013 (1997).
40. Kawamura, T. et al. Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J. Exp. Med. 192, 1491-1500 (2000).
41. Collins, K. B., Patterson, B. K., Naus, G. J., Landers, D. V. & Gupta, P. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nature Med. 6, 475-479 (2000).
42. Hu, Q. et al. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J. Exp. Med. 199, 1065-1075 (2004). This investigation clearly demonstrates that DCs migrating from HIV-1-exposed cervical tissue can efficiently transmit the virus. Inhibition of this pathway can occur only by simultaneous blockade of CD4 and mannose-binding C-type lectin receptors.
43. Cummins, J. E., Jr et al. Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture. Antimicrob. Agents Chemother. 51, 1770-1779 (2007).
44. Turville, S. G. et al. Diversity of receptors binding HIV on dendritic cell subsets. Nature Immunol. 3, 975-983 (2002).
45. Hussain, L. A. & Lehner, T. Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology 85, 475-484 (1995).
46. + T cells in trans.
47. Jameson, B. et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J. Virol. 76, 1866-1875 (2002).
48. Kawamura, T. et al. Significant virus replication in Langerhans cells following application of HIV to abraded skin: relevance to occupational transmission of HIV. J. Immunol. 180, 3297-3304 (2008).
49. + T cells. J. Exp. Med. 182, 2045-2056 (1995).
50. Cameron, P. U. et al. Preferential infection of dendritic cells during human immunodeficiency virus type 1 infection of blood leukocytes. J. Virol. 81, 2297-2306 (2007).
51. Nobile, C. et al. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J. Virol. 79, 5386-5399 (2005).
52. Burleigh, L. et al. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells. J. Virol. 80, 2949-2957 (2006).
53. Turville, S. G. et al. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103, 2170-2179 (2004).
54. Gummuluru, S., Rogel, M., Stamatatos, L. & Emerman, M. Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J. Virol. 77, 12865-12874 (2003).
55. Boggiano, C., Manel, N. & Littman, D. R. Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN. J. Virol. 81, 2519-2523 (2007).
56. Wang, J. H., Janas, A. M., Olson, W. J. & Wu, L. Functionally distinct transmission of human immunodeficiency virus type 1 mediated by immature and mature dendritic cells. J. Virol. 81, 8933-8943 (2007).
57. de Witte, L. et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nature Med. 13, 367-371 (2007). This study showed that HIV-1 captured by the C-type lectin receptor langerin was internalized into Birbeck granules and degraded, therefore preventing HIV-1 transmission by skin LCs.
58. Savina, A. et al. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126, 205-218 (2006).
59. Prakash, M., Kapembwa, M. S., Gotch, F. & Patterson, S. Chemokine receptor expression on mucosal dendritic cells from the endocervix of healthy women. J. Infect. Dis. 190, 246-250 (2004).
60. Hladik, F. et al. Dendritic cell-T-cell interactions support coreceptor-independent human immunodeficiency virus type 1 transmission in the human genital tract. J. Virol. 73, 5833-5842 (1999). This is the first reported observation that DCs isolated from the vaginal mucosa internalize HIV-1 into cytoplasmic endosomes and produce new virions that bud from the cell membrane.
61. Spira, A. I. et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183, 215-225 (1996). In this study, intravaginal inoculation of macaques with SIV led to the infection of stromal DCs and cells in the draining lymph nodes within two days.
62. Hu, J., Pope, M., Brown, C., O'Doherty, U. & Miller, C. J. Immunophenotypic characterization of simian immunodeficiency virus- infected dendritic cells in cervix, vagina, and draining lymph nodes of rhesus monkeys. Lab. Invest. 78, 435-451 (1998).
63. Bhoopat, L. et al. In vivo identification of Langerhans and related dendritic cells infected with HIV-1 subtype E in vaginal mucosa of asymptomatic patients. Mod. Pathol. 14, 1263-1269 (2001).
64. Nestle, F. O. & Nickoloff, B. J. Deepening our understanding of immune sentinels in the skin. J. Clin. Invest. 117, 2382-2385 (2007).
65. Turville, S. G., Aravantinou, M., Stossel, H., Romani, N. & Robbiani, M. Resolution of de novo HIV production and trafficking in immature dendritic cells. Nature Methods 5, 75-85 (2008).
66. Johansson, E. L., Rudin, A., Wassen, L. & Holmgren, J. Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology 96, 272-277 (1999).
67. Edwards, J. N. & Morris, H. B. Langerhans' cells and lymphocyte subsets in the female genital tract. Br. J. Obstet. Gynaecol. 92, 974-982 (1985).
68. + Th1 phenotype. J. Immunol. 163, 2306-2313 (1999).
69. Zhang, L. et al. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J. Virol. 72, 5035-5045 (1998).
70. Prakash, M., Kapembwa, M. S., Gotch, F. & Patterson, S. Higher levels of activation markers and chemokine receptors on T lymphocytes in the cervix than peripheral blood of normal healthy women. J. Reprod. Immunol. 52, 101-111 (2001).
71. + T cells in the macaque genital mucosa as the predominant targets for SIV infection, and they noted that both activated and resting T cells propagate virus.
72. + T cells express high levels of CCR5 and are rapidly depleted in simian immunodeficiency virus infection. J. Infect. Dis. 187, 769-776 (2003).
73. + T cells in transmission and acute simian immunodeficiency virus infection. Proc. Natl Acad. Sci. USA 101, 5640-5645 (2004).
74. Picker, L. J. & Watkins, D. I. HIV pathogenesis: the first cut is the deepest. Nature Immunol. 6, 430-432 (2005).
75. Tuttle, D. L., Harrison, J. K., Anders, C., Sleasman, J. W. & Goodenow, M. M. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J. Virol. 72, 4962-4969 (1998).
76. Meng, G. et al. Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa. J. Infect. Dis. 182, 785-791 (2000).
77. Saphire, A. C., Bobardt, M. D., Zhang, Z., David, G. & Gallay, P. A. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J. Virol. 75, 9187-9200 (2001).
78. Marechal, V. et al. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J. Virol. 75, 11166-11177 (2001).
79. Sharova, N., Swingler, C., Sharkey, M. & Stevenson, M. Macrophages archive HIV-1 virions for dissemination in trans. EMBO J. 24, 2481-2489 (2005).
80. Groot, F., Welsch, S. & Sattentau, Q. J. Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood, 22 February 2008 (doi:10.1182/blood-2007-12-130070).
81. Harada, H., Goto, Y., Ohno, T., Suzu, S. & Okada, S. Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1. Eur. J. Immunol. 37, 2148-2155 (2007).
82. Rappocciolo, G. et al. DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes. PLoS Pathog. 2, e70 (2006).
83. Leon, B., Lopez-Bravo, M. & Ardavin, C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26, 519-531 (2007).
84. Wu, L. & KewalRamani, V. N. Dendritic-cell interactions with HIV: infection and viral dissemination. Nature Rev. Immunol. 6, 859-868 (2006).
85. + T cells.
86. Pope, M. et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78, 389-398 (1994). This investigation showed that DCs and T cells derived from human epithelium form stable conjugates which can enhance HIV replication.
87. Geijtenbeek, T. B. et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100, 575-585 (2000).
88. McDonald, D. et al. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300, 1295-1297 (2003). The investigators introduce the concept of an infectious synapse between DCs and T cells to which HIV is recruited on the DC side and CD4 and CCR5 on the T-cell side, thus promoting efficient in trans infection.
89. Arrighi, J. F. et al. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J. Exp. Med. 200, 1279-1288 (2004).
90. Wiley, R. D. & Gummuluru, S. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc. Natl Acad. Sci. USA 103, 738-743 (2006).
91. Jolly, C. & Sattentau, Q. J. Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains. J. Virol. 81, 7873-7884 (2007).
92. Jolly, C. & Sattentau, Q. J. Retroviral spread by induction of virological synapses. Traffic 5, 643-650 (2004).
93. Sherer, N. M. et al. Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nature Cell Biol. 9, 310-315 (2007). Retroviruses are transmitted between cells not only across large-surface interfaces (infectious synapses) but also through movement along the outer surface of thin filopodial bridges that are extended from the non-infected to the infected cells.
94. Hope, T. J. Bridging efficient viral infection. Nature Cell Biol. 9, 243-244 (2007).
95. Watkins, S. C. & Salter, R. D. Functional connectivity between immune cells mediated by tunneling nanotubules. Immunity 23, 309-318 (2005).
96. Cavrois, M., Neidleman, J., Kreisberg, J. F. & Greene, W. C. In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions. PLoS Pathog. 3, e4 (2007).
97. Kwon, D. S., Gregorio, G., Bitton, N., Hendrickson, W. A. & Littman, D. R. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 16, 135-144 (2002).
98. Granelli-Piperno, A., Finkel, V., Delgado, E. & Steinman, R. M. Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells. Curr. Biol. 9, 21-29 (1999).
99. + T lymphocytes. J. Immunol. 178, 3177-3185 (2007).
100. Ganesh, L. et al. Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies. J. Virol. 78, 11980-11987 (2004).
101. Chen, P., Hubner, W., Spinelli, M. A. & Chen, B. K. Predominant mode of HIV transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J. Virol. 81, 12582-12595 (2007).
102. McCoombe, S. G. & Short, R. V. Potential HIV-1 target cells in the human penis. AIDS 20, 1491-1495 (2006).
103. Patterson, B. K. et al. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am. J. Pathol. 161, 867-873 (2002).
104. Donoval, B. A. et al. HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. Am. J. Clin. Pathol. 125, 386-391 (2006).
105. Meier, A. S., Bukusi, E. A., Cohen, C. R. & Holmes, K. K. Independent association of hygiene, socioeconomic status, and circumcision with reduced risk of HIV infection among Kenyan men. J. Acquir. Immune Defic. Syndr. 43, 117-118 (2006).
106. Gray, R. H. et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369, 657-666 (2007).
107. Quinn, T. C. Circumcision and HIV transmission. Curr. Opin. Infect. Dis. 20, 33-38 (2007).
108. Wawer, M. J. et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 191, 1403-1409 (2005).
109. Pudney, J. & Anderson, D. J. Immunobiology of the human penile urethra. Am. J. Pathol. 147, 155-165 (1995).
110. McClure, C. P. et al. HIV coreceptor and chemokine ligand gene expression in the male urethra and female cervix. AIDS 19, 1257-1265 (2005).
111. Miller, C. J. et al. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J. Virol. 63, 4277-4284 (1989).
112. Cohen, M. S. et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 349, 1868-1873 (1997).
113. Krieger, J. N. et al. Vasectomy and human immunodeficiency virus type 1 in semen. J. Urol. 159, 820-825; discussion 825-826 (1998).
114. Pudney, J., Oneta, M., Mayer, K., Seage, G., 3rd & Anderson, D. Pre-ejaculatory fluid as potential vector for sexual transmission of HIV-1. Lancet 340, 1470 (1992).
115. Ilaria, G. et al. Detection of HIV-1 DNA sequences in pre-ejaculatory fluid. Lancet 340, 1469 (1992).
116. Brenchley, J. M., Price, D. A. & Douek, D. C. HIV disease: fallout from a mucosal catastrophe? Nature Immunol. 7, 235-239 (2006).
117. + T cells occurs in the intestinal tract of neonatal rhesus macaques in acute SIV infection. Blood 109, 1174-1181 (2007).
118. + T cells in multiple tissues during acute SIV infection. Nature 434, 1093-1097 (2005).
119. + T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200, 761-770 (2004).
120. Haase, A. T. Perils at mucosal front lines for HIV and SIV and their hosts. Nature Rev. Immunol. 5, 783-792 (2005).
121. HIV/AIDS among men who have sex with men, 2007. CDC HIV/AIDS Fact Sheet. Centers for Diseases Control and Prevention, Atlanta. [online] 〈http://www. cdc.gov/hiv/topics/msm/resources/factsheets/msm.htm〉
122. The Global HIV/AIDS pandemic. Morb. Mort. Wkly. Rep. 55, 841-844 (2006).
123. Page-Shafer, K. et al. Risk of HIV infection attributable to oral sex among men who have sex with men and in the population of men who have sex with men. AIDS 16, 2350-2352 (2002).
124. Aceijas, C., Stimson, G. V., Hickman, M. & Rhodes, T. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 18, 2295-2303 (2004).
125. Lehman, D. A. & Farquhar, C. Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev. Med. Virol., 381-403 (2007).
126. Galvin, S. R. & Cohen, M. S. The role of sexually transmitted diseases in HIV transmission. Nature Rev. Microbiol. 2, 33-42 (2004).
127. Royce, R. A., Sena, A., Cates, W., Jr. & Cohen, M. S. Sexual transmission of HIV. N. Engl. J. Med. 336, 1072-1078 (1997).
128. Halperin, D. T. Heterosexual anal intercourse: prevalence, cultural factors, and HIV infection and other health risks, Part I. Aids Patient Care STDS 13, 717-730 (1999).
129. Sowinski et al. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nature Cell Biol. 10, 211-219 (2008).